Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT00671112
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2008-05-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
Brian Hill, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-05-02
First Submit QC Date:
None
Study First Post Date:
2008-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-27
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED